Note: Javascript is disabled or is not supported by your browser. For this reason, some items on this page will be unavailable. For more information about this message, please visit this page: About CDC.gov

Search our Collections

Advanced Search

Advanced Search

Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.

information icon

information icon

information icon

Clear All Simple Search

Advanced Search

delete_icon

Back to Previous Page

- Add this to...

i

R292K Substitution and Drug Susceptibility of Influenza A(H7N9) Viruses

Published Date:

2013

Publisher's site:

http://dx.doi.org/10.3201/eid1909.130724

Source:

Emerg Infect Dis. 19(9):1521-1524.

Language:

[PDF-562.27 KB]

Details:

Alternative Title:

Emerg Infect Dis

Personal Author:

Sleeman, Katrina ; Guo, Zhu ; Barnes, John ; Shaw, Michael ; Stevens, James ; ... More ▼

Description:

Neuraminidase inhibitors are the only licensed antiviral medications available to treat avian influenza A(H7N9) virus infections in humans. According to a neuraminidase inhibition assay, an R292K substitution reduced antiviral efficacy of inhibitors, especially oseltamivir, and decreased viral fitness in cell culture. Monitoring emergence of R292K-carrying viruses using a pH-modified neuraminidase inhibition assay should be considered.

Subject:

[+]

Document Type:

Journal Article

Place as Subject:

China

Collection(s):

Emerging Infectious Diseases

Main Document Checksum:

[+]

File Type:

Supporting Files:

	13-0724.nxml	text/plain
	license.txt	text/plain

No Related Documents.

You May Also Like:

Characterization of Drug-Resistant Influenza A(H7N9) Variants Isolated From an Oseltamivir-Treated Patient in Taiwan

Personal Author:

Marjuki, Henju ; Mishin, Vasiliy P. ; ...

Published Date:

August 14 2014

Source:

J Infect Dis. 211(2):249-257

Description:

Background.Patients contracting influenza A(H7N9) infection often developed severe disease causing respiratory failure. Neuraminidase (NA) inhibitors ...

File Type:

[PDF - 1.04 MB]

File Type:

[PDF - 1.04 MB]
Monitoring influenza virus susceptibility to oseltamivir using a new rapid assay, iART

Personal Author:

Gubareva, Larisa V ; Fallows, Eric ; ...

Published Date:

May 04 2017

Source:

Euro Surveill. 2017; 22(18)

Description:

A new rapid assay for detecting oseltamivir resistance in influenza virus, iART, was used to test 149 clinical specimens. Results were obtained for 13...

File Type:

[PDF - 427.60 KB]

File Type:

[PDF - 427.60 KB]
Poultry Market Closures and Human Infection with Influenza A(H7N9) Virus, China, 2013–14

Personal Author:

Wu, Peng ; Jiang, Hui ; ...

Published Date:

Nov 2014

Source:

Emerg Infect Dis. 20(11):1891-1894.

Description:

Closure of live poultry markets was implemented in areas affected by the influenza virus A(H7N9) outbreak in China during winter, 2013-14. Our analysi...

File Type:

[PDF - 351.12 KB]

File Type:

[PDF - 351.12 KB]
Oseltamivir-Resistant Pandemic (H1N1) 2009 Virus, Mexico

Personal Author:

Ramirez-Gonzalez, José Ernesto ; Gonzalez-Duran, Elizabeth ; ...

Published Date:

Feb 2011

Source:

Emerg Infect Dis. 17(2):283-286.

Description:

During May 2009-April 2010, we analyzed 692 samples of pandemic (H1N1) 2009 virus from patients in Mexico. We detected the H275Y substitution of the n...

File Type:

[PDF - 329.65 KB]

File Type:

[PDF - 329.65 KB]
Estimating the United States Demand for Influenza Antivirals and the Effect on Severe Influenza Disease During a Potential Pandemic

Personal Author:

O’Hagan, Justin J ; Wong, Karen K. ; ...

Published Date:

May 01 2015

Source:

Clin Infect Dis. 60(0 1):S30-S41.

Description:

Following the detection of a novel influenza strain A(H7N9), we modeled the use of antiviral treatment in the United States to mitigate severe disease...

File Type:

[PDF - 375.35 KB]

File Type:

[PDF - 375.35 KB]